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In Brief
HCF-1 is believed to function as a cofactor for E2F transcription factors, thereby controlling the expression of genes necessary for cell-cycle progression. In this report, Parker et al. demonstrate that HCF-1 recruitment to these promoters may not be mediated by E2F factors themselves but instead as part of a complex with zinc-finger transcription factors THAP11 and ZNF143. This work suggests that a distinct THAP11/ ZNF143/HCF-1 complex contributes to the transcriptional regulatory network controlling cell proliferation.
INTRODUCTION
Host cell factor-1 (HCF-1) is a ubiquitously expressed transcriptional coregulator that has been identified in a variety of transcriptional regulatory complexes. HCF-1 is believed to function as a molecular scaffold, linking sequence-specific transcription factors with enzymes capable of altering the posttranslational modifications of histones and other chromatin-associated proteins (Ajuh et al., 2000; Liang et al., 2009; Kristie, 2006, 2013; Wysocka et al., 2003) . The biological significance of HCF-1-dependent gene expression is underscored by multiple studies demonstrating that HCF-1 function is critical for cell proliferation and cell-cycle progression (Julien and Herr, 2003; Mangone et al., 2010; Reilly et al., 2002; Wysocka et al., 2001) . Evidence suggesting that HCF-1-regulated transcription contributes to cell proliferation was initially provided by Wysocka et al., who showed that loss of HCF-1 chromatin association precedes growth arrest of temperature-sensitive tsBN67 hamster cells, which contain a single proline-to-serine missense mutation (HCF-1 P134S) previously known to disrupt HCF-1 association with the VP16 viral transactivator (Goto et al., 1997; Wysocka et al., 2001) . Subsequent work from the same laboratory revealed that the S phase defect in tsBN67 cells grown at the nonpermissive temperature could be mitigated by inactivation of the retinoblastoma tumor suppressor protein (RB1), leading to the hypothesis that HCF-1 promotes cell proliferation by regulating E2F cell-cycle control genes (Reilly et al., 2002; Tyagi et al., 2007) . E2F family members E2F1, E2F4, and E2F3a have been shown to contain the tetrapeptide HCF-1 binding motif (HBM; [E/D]HxY) and physically interact with HCF-1 (Knez et al., 2006; Tyagi et al., 2007) . E2F1 and E2F4 associate with HCF-1 in HeLa cells, and HCF-1 chromatin occupancy at E2F-regulated genes has been suggested to occur by E2F-mediated recruitment of HCF-1 in a cell-cycle-dependent manner (Tyagi et al., 2007) .
Although the current model proposes that HCF-1 is a direct transcriptional coregulator of E2F proteins, recent evidence suggests that other sequence-specific transcription factors may also play a role in HCF-1 recruitment at cell-cycle and growth control genes. Yu et al. have demonstrated that a ternary complex composed of Yin Yang 1 (YY1), HCF-1, and deubiquitinase BRCA1-associated protein-1 (BAP1) regulates the expression of cell growth and proliferation genes (Yu et al., 2010) . Additionally, work in our laboratory and by others has shown that the Thanatos-associated protein (THAP) domain-containing family of atypical zinc finger transcription factors constitutes a large group of putative HCF-1-associated transcriptional regulators (Dejosez et al., 2008 (Dejosez et al., , 2010 Mazars et al., 2010; Parker et al., 2012) . Mazars et al. have demonstrated that THAP1 recruits HCF-1 to the RRM1 promoter during endothelial cell proliferation, and both THAP1 and HCF-1 are necessary for RRM1 gene expression (Mazars et al., 2010) . We have previously shown that THAP11 is an HCF-1-dependent transcriptional regulator and cell proliferation factor in human colon cancer cells . Interestingly, we found that THAP11 is recruited with HCF-1 at E2F target genes RBL1 and CDC25A, but the functional relevance of this observation remains unknown.
In this report, we provide evidence that HCF-1 recruitment to numerous E2F-bound promoters is mediated not by E2F factors directly, but instead by the joint occupancy of zinc finger transcription factors THAP11 and ZNF143. We further show that THAP11, ZNF143, and HCF-1 assemble into a complex on chromatin and that stable complex association with chromatin is mutually dependent on all three factors. The expression of cell proliferation and cell-cycle control genes is found to be at least partially THAP11/ZNF143/HCF-1 complex dependent, and disruption of this complex results in altered cell-cycle progression and reduced cell proliferation. The present study changes our current view of the role of E2F proteins in HCF-1 recruitment and demonstrates a mechanism of THAP11/ZNF143-mediated HCF-1 recruitment to key cell-cycle progression genes.
RESULTS

HCF-1 Occupancy at E2F1-Bound Promoters
Correlates with THAP11 and ZNF143 Binding Our previous characterization of THAP11 function in human colon cancer cells unexpectedly revealed that THAP11 bound with HCF-1 at RBL1 and CDC25A promoters . HCF-1 recruitment to both RBL1 and CDC25A promoters has been previously shown to function in both an E2F-and cell-cycle-dependent manner (Tyagi et al., 2007) . Nonetheless, we speculated that THAP11 might also play a role in HCF-1 recruitment at these and, perhaps, other E2F target gene promoters. To explore this possibility, we analyzed ENCODE E2F1 chromatin occupancy data sets (Consortium, 2011) for the presence of a previously determined THAP11 binding motif (Dejosez et al., 2010) . This analysis identified 1,702 promoter-proximal candidate THAP11 binding sites located within 400 base pairs of E2F1-bound regions. Comparison of these regions with ENCODE transcription factor chromatin immunoprecipitation sequencing (ChIP-seq) data revealed that these putative THAP11 binding sites frequently lie within experimentally determined ZNF143-bound regions. Direct sequence comparison further showed that the THAP11 binding motif is highly similar to an extended ZNF143 binding motif (Myslinski et al., 2006; Wang et al., 2012) , suggesting THAP11 and ZNF143 may occupy similar DNA sequences. To test if THAP11 or ZNF143 occupy chromatin with HCF-1 at these E2F1-bound promoters, we performed chromatin immunoprecipitation for each factor in HeLa cells and determined binding at 62 candidate THAP11/ZNF143 and E2F-bound promoters, as well as two negative control promoters (HBB and CHRM1). We found that the chromatin occupancy of HCF-1, THAP11, and ZNF143 at these regions was highly correlated, with Pearson pairwise correlation coefficients exceeding 0.90 ( Figures 1A and 1B) , whereas E2F1 binding showed no correlation with either factor (r < 0.19). ChIP-scanning assays performed to determine each factor's promoter-proximal positioning revealed that THAP11, HCF-1, and ZNF143 share a nearly identical binding profile that was distinct from that of E2F1 ( Figure 1C) . Moreover, the location of maximum ChIP signal observed for THAP11, HCF-1, and ZNF143 at CDC25A, CDC6, and MCM3 promoter-proximal regions corresponds with a conserved THAP11/extended ZNF143 binding motif (Figure 1D) . Similar results demonstrating that HCF-1 binding is coincident with THAP11 and ZNF143 rather than E2F binding were also obtained in T98G glioblastoma cells, suggesting these findings are not cell type specific ( Figure S1 ). Together, these data suggest that at a subset of E2F target genes, THAP11, and/or ZNF143 may directly recruit HCF-1 to chromatin.
THAP11, ZNF143, and HCF-1 Chromatin Occupancy Are Interdependent
To test the possibility that THAP11 and/or ZNF143 is necessary for HCF-1 recruitment, we next performed a series of ChIP assays examining occupancy of each factor at these 62 promoters following THAP11, ZNF143, or HCF-1 knockdown in HeLa cells. THAP11 knockdown resulted in a significant decrease of both HCF-1 and ZNF143 chromatin occupancy (Figure 2A ), but depletion of THAP11 from chromatin was neither uniform nor complete. Pairwise scatterplots of HCF-1 or ZNF143 chromatin occupancy relative to THAP11 revealed good correlation between the extent of THAP11 depletion and corresponding loss of HCF-1 and ZNF143 binding ( Figure 2B ). Importantly, neither HCF-1 nor ZNF143 protein levels were changed in THAP11 knockdown cells ( Figure 2C ), suggesting that the decrease in HCF-1 and ZNF143 chromatin occupancy results from their altered recruitment to these promoters.
A similar set of experiments was performed to determine the role of ZNF143 in THAP11 and HCF-1 recruitment. As shown in Figure 2D , HeLa cells expressing ZNF143 short hairpin RNA (shRNA) show a significant reduction in average recruitment of ZNF143, THAP11, and HCF-1 at these 62 target genes. Similarly to what was observed for THAP11, the amount of ZNF143 that remained bound at these promoters was variable and ranged from unchanged to less than 25% remaining ( Figure 2E ), despite substantial depletion of ZNF143 protein ( Figure 2F ). Decreases in THAP11 and HCF-1 promoter occupancy upon ZNF143 knockdown closely paralleled that of ZNF143 ( Figure 2E ). Because THAP11 and HCF-1 total protein amounts were unchanged upon ZNF143 knockdown ( Figure 2F ), these results suggest that ZNF143 contributes to both THAP11 and HCF-1 recruitment to chromatin. We previously demonstrated that THAP11 not only recruits but also requires HCF-1 for chromatin association . To determine if ZNF143 chromatin association has a similar dependence on HCF-1, we performed THAP11 and ZNF143 ChIP assays in HCF-1 knockdown cells. Confirming our previous observations, HCF-1 knockdown in HeLa cells resulted in a robust decrease in THAP11 promoter occupancy ( Figure 2G ). Unexpectedly, however, HCF-1 knockdown also resulted in a significant decrease in ZNF143 binding ( Figure 2G ). Unlike THAP11 and ZNF143 shRNAs, HCF-1 knockdown resulted in at least a 50% reduction of occupancy at most promoters examined ( Figure 2H ). Nevertheless, both THAP11 and ZNF143 relative promoter occupancy showed a strong linear relationship with remaining HCF-1 binding. Because neither THAP11 nor ZNF143 protein levels were changed ( Figure 2I ), these results likely suggest that HCF-1 is necessary for both THAP11 and ZNF143 binding at these promoters. Collectively, the results presented in Figure 2 indicate that THAP11 and ZNF143 are critical mediators of HCF-1 occupancy at these 62 E2F1-bound promoters and further demonstrate that THAP11, ZNF143, and HCF-1 chromatin binding are mutually dependent.
THAP11, ZNF143, and HCF-1 Form a Complex on Chromatin
The nearly identical promoter-proximal positioning ( Figure 1C ) and interdependent chromatin association (Figure 2 ) observed for THAP11, HCF-1, and ZNF143 could indicate formation of a complex between these factors. To explore this possibility further, a series of sequential chromatin immunoprecipitation experiments (ChIP-reChIP) was performed to determine if THAP11, HCF-1, and ZNF143 simultaneously co-occupy the promoters of E2F target genes involved in cell proliferation and cell-cycle progression. Consistent with this hypothesis, we found that ZNF143 was robustly reChIP'ed at all THAP11-bound promoters examined ( Figure 3A ). Similar results were obtained when the order of antibodies was reversed (i.e., ZNF143 ChIP followed by THAP11 reChIP; Figure 3B ) indicating that THAP11 and ZNF143 indeed occupy these promoters simultaneously. Sequential ChIP assays were next used to determine if THAP11 and ZNF143 co-occupy these promoters together with HCF-1. As shown in Figure 3C , HCF-1-bound promoters were effectively reChIP'ed by either anti-THAP11 or anti-ZNF143 antibodies, thus confirming that THAP11, ZNF143, and HCF-1 likely bind these promoters as a complex. The lack of reChIP signal observed for THAP11 and ZNF143 at RRM1 following HCF-1 ChIP ( Figure 3C ) is consistent with previous reports from our laboratory and others suggesting that HCF-1 recruitment to RRM1 is mediated not by THAP11 but instead by THAP1 (Mazars et al., 2010; Parker et al., 2012) . This internal control not only confirms the fidelity of the sequential ChIP assay but also suggests that ZNF143 co-occupancy is not broadly applicable to all THAP protein/ HCF-1 complexes.
Although these results strongly indicate the formation of a THAP11/ZNF143/HCF-1 complex, it remains possible that the observed THAP11 and ZNF143 chromatin co-occupancy may result from separate protein-DNA interactions that are indiscernible by conventional chromatin immunoprecipitation. To rule out this possibility, we performed THAP11 ChIP and subjected the protein-G bead-bound immunoprecipitated material to extensive Benzonase nuclease digestion followed by several stringent washes to remove proteins bound exclusively through protein-nucleic acid interactions. After formaldehyde crosslinks were reversed, ZNF143 recovery was monitored by western blot, whereas the effectiveness of DNA digestion was determined by quantitative PCR of THAP11/ZNF143-bound promoters. As shown in Figure 3D , THAP11 ChIP recovered a significant fraction of chromatin-bound ZNF143, which was unaffected by Benzonase treatment despite a near complete digestion of THAP11-associated DNA ( Figure 3E ). Because the quantitative PCR (qPCR) amplicons used to monitor Benzonase digestion span only 70-150 bp and either flank or lie immediately adjacent to the presumptive THAP11/extended ZNF143 binding sites, the above results suggest that THAP11, HCF-1, and ZNF143 likely co-occupy these sites as a complex. To determine whether this complex is formed exclusively on chromatin, we performed coimmunoprecipitations from soluble nuclear extracts. As expected from previous studies, HCF-1 immunoprecipitation recovered a large amount of soluble THAP11, whereas from the same material a smaller fraction of ZNF143 was also recovered ( Figure 3F ). We find that under identical conditions, THAP11 immunoprecipitation recovered less albeit detectable ZNF143, indicating that THAP11 can interact with both HCF-1 and ZNF143 in soluble nuclear extracts as well as on chromatin.
E2F Binding Is Dispensable for HCF-1 Recruitment to Chromatin
The finding that THAP11 and ZNF143 are necessary for HCF-1 recruitment to E2F target genes was somewhat surprising because previous reports suggested that E2F proteins (E2F1, E2F3a, and E2F4) directly recruit HCF-1 to chromatin (Tyagi et al., 2007; Tyagi and Herr, 2009) . To independently examine the role of E2F binding activity in HCF-1 recruitment, we performed HCF-1 ChIP in E2F1 knockdown HeLa cells. We find that, under conditions where E2F1 protein and chromatin occupancy are significantly depleted, HCF-1 recruitment at the same loci is mostly unchanged (Figures 4A and 4B) . E2F4 knockdown similarly failed to disrupt HCF-1 promoter occupancy at prototypical E2F target genes RBL1, CDC25A, CDC6, and MCM3 ( Figure S2A ). Because remaining E2F members may compensate for loss of individual E2F proteins (Kong et al., 2007) , we next used knockdown of the E2F obligate heterodimeric partner DP1 to determine if E2F functional redundancy explains why HCF-1 promoter occupancy is insensitive to knockdown of individual E2Fs. We find that, whereas depletion of DP1 is sufficient to simultaneously reduce both E2F1 and E2F3 binding at these promoters, HCF-1 binding is largely unchanged (Figures 4C and 4D) , suggesting direct E2F-mediated recruitment may not be the primary mechanism of HCF-1 occupancy at these E2F-bound promoters after all. To confirm this finding, we generated T98G cells containing a chromosomally integrated wild-type or E2F binding site mutant RBL1 promoter construct ( Figure 4E ) and monitored HCF-1 occupancy at these ectopic loci by ChIP. The specific E2F binding site mutations employed here (D) ZNF143 coprecipitation with THAP11 in formaldehyde-crosslinked SW620 cells is Benzonase resistant. THAP11 ChIP-enriched material was treated with or without Benzonase. Digested nucleic acids and any associated proteins were removed by extensive washing, and remaining ZNF143 was detected by immunoblot. Input corresponds to 5% of starting material. (E) Confirmation of Benzonase digestion to remove THAP11-associated DNA was determined by qPCR using primers corresponding to THAP11 binding sites at indicated gene promoters. (F) ZNF143 associates with both THAP11 and HCF-1 in soluble nuclear extracts. HCF-1 and THAP11 were immunoprecipitated from SW620 nuclear extracts and coprecipitated ZNF143 was detected by immunoblot. In the top and middle panels, 10% of the immunoprecipitation was loaded for immunoblot. In the bottom panel, 90% of the immunoprecipitation was analyzed. In have been previously shown to eliminate E2F binding at the endogenous Rbl1 promoter in both mouse embryonic stem cells and fibroblasts (Burkhart et al., 2010) . Likewise, we find that E2F recruitment, as determined by DP1 ChIP, is reduced to near-background levels at the mutant RBL1 promoter (Figure 4F , compare DP1 ChIP at promoter and luciferase). HCF-1 occupancy, however, was unperturbed by the E2F binding site mutations ( Figure 4F ), further reinforcing the idea that HCF-1 promoter occupancy is independent from that of E2F proteins.
Although the above results demonstrate that E2F binding is dispensable for HCF-1 recruitment at promoters also co-occupied by THAP11 and ZNF143, E2Fs might still play an important role in HCF-1 recruitment, especially at genes that lack THAP11 and ZNF143 occupancy. To test this hypothesis, we first determined HCF-1 occupancy on promoters of E2F target genes without discernible THAP11/ZNF143 binding motifs near their known E2F binding sites. In both T98G ( Figure 4G , left panel) and HeLa cells (data not shown), we find that HCF-1 recruitment to THAP11/ZNF143-free MCM4 and PCNA promoters is markedly lower than HCF-1 binding at the E2F/THAP11/ZNF143 co-occupied RBL1 promoter, despite comparable levels of E2F occupancy. Similar results were found when HCF-1 recruitment at the CDC25A promoter, bound by THAP11, ZNF143, and E2F, was compared to HCF-1 binding at E2F-only promoters E2F1, CCNA2, CCNE1, and CDK1 ( Figure 4G , right panel). In both instances, total E2F binding, as determined by DP1 ChIP, was similar between THAP11/ZNF143-bound and -unbound promoters, suggesting that E2F binding alone may be insufficient to mediate substantial HCF-1 recruitment.
The small amount of HCF-1 bound at these promoters precluded a more detailed investigation of whether HCF-1 recruitment to THAP11/ZNF143-free promoters is dependent on E2F1. To circumvent this issue, we used available ChIP-seq data sets to identify a candidate set of promoters that were enriched for HCF-1 and E2F1 but devoid of THAP11 and ZNF143. Fourteen of these promoters were chosen at random and validated by ChIP-qPCR to have virtually no detectable THAP11 and ZNF143 binding ( Figure S2B ). Knockdown of E2F1 in HeLa cells resulted in substantial depletion of E2F1 across all chosen THAP11/ZNF143-free promoters, yet no change in HCF-1 occupancy was observed ( Figure 4H ). These findings strongly suggest that HCF-1 recruitment at E2F target genes is independent of E2F binding regardless of THAP11 and ZNF143 co-occupancy.
To extend the above observations to a genome-wide scale, we analyzed previously published and publicly available ChIP-seq data. Although no single data set covered all of the proteins of interest, we chose data sets that were generated in the same cell line (HeLa-S3). E2F1 ChIP-seq has been performed by the ENCODE consortium (Consortium, 2011) , whereas ChIP-seq data for THAP11, ZNF143, and HCF-1 was recently published by Michaud et al. (2013) . In order to compare these data, we used identical parameters to first align raw sequencing reads from all data sets to the human hg19 reference genome and then call peaks using HOMER ChIP-seq analysis software (see Supplemental Experimental Procedures for details).
Proteins that are found on chromatin in a single complex and are responsible for each other's occupancy should have significant spatial overlap, as observed by ChIP scanning in Figure 1C . To extend this observation to a genome-wide scale for ZNF143, THAP11, and E2F1 in reference to HCF-1 binding, we analyzed the distribution of HCF-1 ChIP-seq peaks relative to the three transcription factors. For colocalized peaks (no more than 500 bases apart), E2F1 is found in the vicinity of more HCF-1 peaks (2,019) than either ZNF143 (1,300) or THAP11 (471, Figure S3A) . However, at the genomic loci where these proteins are colocalized, HCF-1 appears to bind very closely to THAP11 and ZNF143 binding sites (90% of peaks within $100 bases) but has a much broader distribution relative to E2F1 (90% of peaks within $350 bases, Figure 5A ). Because E2F1 and THAP11/ZNF143/HCF-1 data were generated by independent laboratories, we wondered whether the difference in the HCF-1 relative distribution could be attributed to variations between experiments. To this end, we performed the same analysis on an additional ZNF143 data set published by ENCODE ( Figure S3B ). Although we observed an increased range of HCF-1 peak distances to ENCODE ZNF143 (90% of peaks within 200 bases), this distribution was still significantly narrower than that of ENCODE E2F1 peaks, suggesting that the observed difference in relative HCF-1 distribution is unlikely to be an experimental artifact.
Additionally, we analyzed the relationship of ChIP-seq tag densities (corresponding to amount of chromatin occupancy) between HCF-1 and the other proteins. Within a chromatinbound complex, it can be expected that the chromatin occupancy of one protein should correlate with the occupancy of proteins in the same complex. We have observed this phenomenon for THAP11, ZNF143, and HCF-1 but not E2F1 ( Figures 1A,  2B , 2E, 2H, and 4A). Similarly, when ChIP-seq tag densities are compared between these four proteins on a genome-wide scale, we observe a much better pairwise correlation between HCF-1 and THAP11 ( Figure 5B ) or ZNF143 ( Figure 5C ) than we do between HCF-1 and E2F1 ( Figure 5D ). Relatively good correlation (r = 0.67) is also observed between HCF-1 and ZNF143 peaks derived from the ENCODE data set ( Figure S3C) .
We considered the possibility that the dominant role of THAP11/ZNF143 in HCF-1 recruitment may obscure the effect that E2F1 has on HCF-1 occupancy at some of these loci. This could potentially explain the poor correlation observed for E2F1 and HCF-1 chromatin occupancy when THAP11/ZNF143 co-occupied loci are included in the analysis. To overcome this possible limitation, we focused on loci where E2F1 ChIP-seq peaks were directly overlapping with HCF-1 (by at least 50% of the peak width) and excluded E2F1-HCF-1 loci co-occupied by THAP11 or ZNF143 ( Figure S3D ). Such filtering should increase the likelihood of identifying E2F1-dependent HCF-1 recruitment to chromatin. Nevertheless, this restrictive subset of E2F1 peaks still showed no increase in correlation with chromatin occupancy of HCF-1. The genome-wide data analysis strongly supports our gene-specific observations (Figures 4G and 4H) and suggests that THAP11 and ZNF143 but not E2F1 play a dominant role in HCF-1 recruitment to chromatin.
HCF-1 recruitment at several of the genes identified here has been shown to occur in a cell-cycle-dependent manner (Tyagi et al., 2007) . To determine if THAP11 and ZNF143 contribute to the cell-cycle-dependent recruitment of HCF-1 previously attributed to E2F proteins, we examined the occupancy of HCF-1, (legend continued on next page) THAP11, ZNF143, E2F1, and E2F4 by ChIP at RBL1, CDC25A, CDC6, and MCM3 promoters in synchronized HeLa cells. HeLa cells were enriched at prometaphase by sequential thymidine and nocodazole treatments. Following release from nocodazole block, cells were collected every 1-2 hr. Progression through mitosis into G1 and S phases was monitored by immunoblotting for histone H3 serine 10 phosphorylation (H3S10P) and cyclin E1 ( Figure 6A ). THAP11, ZNF143, and HCF-1 associate with E2F target promoters in early G1 (at approximately 2 hr after nocodazole release) and coincided with maximal E2F4 recruitment ( Figure 6B ). Because E2F4 knockdown in asynchronously growing HeLa cells failed to reduce HCF-1 occupancy at these promoters ( Figure S2A ), we suggest that recruitment of HCF-1 in early G1 is likely to be mediated by THAP11 and ZNF143. Additionally, whereas E2F4 binding steadily decreases as cells progress through G1, THAP11, ZNF143, and HCF-1 remained promoter bound with maximum occupancy achieved prior to peak E2F1 binding ( Figure 6B ). The remarkable similarity in the cell-cycle-dependent binding profiles of THAP11, HCF-1, and ZNF143, in conjunction with our ChIP data in knockdown cells, strongly suggests that THAP11 and ZNF143 are the primary determinants of cell-cycle-dependent HCF-1 recruitment at these promoters.
THAP11/ZNF143/HCF-1 Complex Regulates Expression of Cell-Cycle Genes and Is Necessary for Cell Proliferation
To determine if the promoters occupied by THAP11, ZNF143, and HCF-1 are also regulated by this complex, we examined the mRNA expression of THAP11/ZNF143/HCF-1 target genes in HCF-1 knockdown HeLa cells. HCF-1 knockdown was used to deplete the THAP11/ZNF143/HCF-1 complex from target gene promoters because HCF-1 knockdown results in a greater decrease in complex occupancy than knockdown of either THAP11 or ZNF143 alone (Figure 2 ). HeLa cells expressing HCF-1 shRNA were collected 4 days posttransduction and used to determine the mRNA expression of 32 genes that showed the greatest change in complex occupancy following HCF-1 knockdown ( Figure 2G ). As shown in Figure 7A , HCF-1 knockdown resulted in a significant change in the expression of 27 out of the 32 genes. Notable among the mRNAs downregulated by HCF-1 knockdown are key genes involved in cell proliferation (MAP3K10, FGFR1, ACLY), G1/S phase progression (CDC25A, CDC6, MCM3, RBL1), and mitosis (BUB1B, BOD1, RANGAP1). Similar results were obtained when the THAP11/ZNF143/HCF-1 complex was disrupted by simultaneous small interfering RNA (siRNA)-mediated knockdown of THAP11 and ZNF143 (Figures S4A and S4B) , suggesting that these genes are indeed functional targets of a THAP11/ZNF143/HCF-1 complex.
Consistent with HCF-1-dependent expression of cell proliferation and cell-cycle progression genes, we found that HCF-1 depletion resulted in an almost complete reduction in cell proliferation ( Figure 7B ). Similar to our previous results in colon cancer cells , we found that THAP11 knockdown also decreases HeLa cell proliferation, albeit less than HCF-1 knockdown ( Figure 7B ). Cell-cycle analysis revealed that HCF-1 knockdown results in an almost 2-fold increase in G2/M phase HeLa cells ( Figure 7C, top panels) , which is consistent with previous reports suggesting a role for HCF-1 during cytokinesis Herr, 2003, 2004; Reilly et al., 2002) . Importantly, we found that THAP11 knockdown recapitulates the G2/M cell-cycle defect observed in HCF-1 knockdown HeLa cells ( Figure 7C , bottom panels) suggesting this phenotype may arise from perturbation of the THAP11/ZNF143/HCF-1 complex. Surprisingly, no accumulation of G1 phase HeLa cells was observed after HCF-1 knockdown despite previous reports indicating otherwise Herr, 2003, 2004; Tyagi et al., 2007) . However, HCF-1 knockdown did result in significant increases in G1 phase cells in both T98G glioblastoma and SW620 colon carcinoma cells ( Figure S4C) , suggesting that the cell-cycle defects resulting from HCF-1 depletion are context dependent. The lack of G1/S arrest observed in HCF-1 knockdown HeLa cells may stem from the expression of human papillomavirus (HPV) E6 and E7 oncoproteins in these HPV18-positive cells. Highrisk HPV E6 targets p53 for proteasome-mediated degradation, whereas E7 binds to and inactivates hypophosphorylated RB1 (Dyson et al., , 1992 Mü nger et al., 1989; Scheffner et al., 1990) . The E7-mediated disruption of repressive RB1/E2F complexes results in aberrant E2F target gene expression including genes critical for G1/S phase progression (reviewed in Moody and Laimins, 2010) . Consistent with numerous previous studies demonstrating a role for E6 and E7 expression in HeLa cell proliferation (DeFilippis et al., 2003; Goodwin and DiMaio, 2000; Gu et al., 2006; Hall and Alexander, 2003; Johung et al., 2007; Psyrri et al., 2004; Tang et al., 2006) , we find that knockdown of HPV18 E6/E7 mRNA ( Figure 7D ) alone is sufficient to result in a significant G1/S arrest ( Figure 7E ). This result suggests that the role of THAP11/ZNF143/HCF-1 in HeLa cell G1/S progression is likely masked by the expression of HPV18 E6 and E7 in these cells.
Because cell death is a frequent consequence of mitotic delay (Neumann et al., 2010) knockdown HeLa cells at 6 days posttransduction had a significant increase in both Annexin V positive and Annexin V/PI double-positive cells ( Figure 7F , middle panels). Two days later, only 23% of HCF-1 knockdown cells and 42% of THAP11 knockdown cells were viable (Annexin V and PI negative) compared to 86% viability for control knockdown cells ( Figure 7F , bottom panels). The larger decrease in cell viability observed in HCF-1 versus THAP11 knockdown ( Figure 7F ) likely explains the proliferation difference observed in Figure 7B . Collectively, these data suggest that a transcriptional regulatory complex consisting of HCF-1, THAP11, and ZNF143 contributes to the expression of genes critical for cell proliferation and cell-cycle progression.
DISCUSSION
HCF-1 is a well-studied transcriptional coregulator with important functions in cell proliferation and cell-cycle progression. In this work, we demonstrate that a complex composed of HCF-1 and zinc-finger transcription factors THAP11 and ZNF143 is the predominant mechanism for HCF-1 recruitment at many E2F-regulated promoters. Furthermore, we demonstrate that THAP11/ZNF143/HCF-1 complex-dependent expression of cell-cycle control genes is necessary for cell proliferation, cellcycle progression, and maintenance of cell viability. This work significantly alters the current model of HCF-1-directed transcription and also suggests that the THAP11/ZNF143/HCF-1 complex is a novel component of the transcriptional regulatory network controlling cell proliferation.
The discovery that HCF-1 is recruited to E2F-target genes offers an appealing explanation for its role in cell-cycle regulation. The current model of HCF-1 recruitment at these promoters is based on a previous investigation (Tyagi et al., 2007) that suggests HCF-1 is a direct cofactor for E2F proteins, evidenced by the finding that HCF-1 physically interacts with E2Fs and occupies the promoters of several E2F-regulated cell-cycle control genes. We now make several key observations that alter this model of E2F-dependent HCF-1 recruitment and suggest a previously unrecognized role for THAP11 and ZNF143 in HCF-1 recruitment to, and regulation of, E2F-target genes. First, we find that the amount of HCF-1 bound at E2F1-occupied promoters correlates with THAP11 and ZNF143 rather than E2F1. Additionally, both the cell-cycle-dependent recruitment and spatial distribution of promoter-bound HCF-1 are highly coincident with THAP11 and ZNF143 but not E2F1 occupancy, suggesting that THAP11 and ZNF143 are likely the key determinants of HCF-1 recruitment to these loci. Strongly supporting this hypothesis is the finding that knockdown of either THAP11 or ZNF143 is sufficient to significantly reduce HCF-1 recruitment at E2F-bound promoters. The inability to release HCF-1 from these promoters following E2F1, E2F4, or DP1 knockdown is a key feature of this work and is an attempt to directly ascertain the role of E2F proteins in HCF-1 recruitment at cell-cycle control genes. Although these findings suggest that HCF-1 may not be a direct E2F-recruited coregulator, multiple studies have nonetheless affirmed that E2F-dependent recruitment of chromatin modifying activities such as CBP/p300, KAT2A/GCN5, KAT2B/ PCAF, and KAT5/TIP60 histone acetyltransferase complexes is essential for expression of cell-cycle control genes (Brehm et al., 1998; Litovchick et al., 2007; Louie et al., 2004; Magnaghi-Jaulin et al., 1998; Taubert et al., 2004) . Accordingly, we suggest that distinct THAP11/ZNF143/HCF-1 and E2F-recruited transcriptional regulatory complexes may cooperate to control the expression of genes necessary for cell proliferation.
The importance of THAP11 in HCF-1 recruitment to E2F-regulated promoters is further strengthened by the similarity of cell physiological response to the knockdown of these factors. Under both THAP11 and HCF-1 knockdown conditions, we observe a substantial G2/M arrest in HeLa cells, which likely leads to the subsequent apoptosis observed in both cases. Consistent with these results, HCF-1 depletion has been shown to result in upregulated SETD8/KMT5A/PR-Set7 leading to aberrant mitotic histone H4K20 monomethylation and corresponding defects in mitosis and cytokinesis (Julien and Herr, 2004) . In addition to this mechanism, the data reported here suggest that HCF-1 may also contribute to G2/M phase progression by directly regulating genes involved in mitotic spindle formation. The THAP11/ZNF143/HCF-1 complex occupies the promoters of mitotic spindle assembly checkpoint genes BUB1B and BUB3 (Lara-Gonzalez et al., 2012) , the Ran GTPase activating protein RANGAP1 (Joseph et al., 2004) , the cohesion acetyltransferase ESCO2 (Whelan et al., 2012) , and BOD1, a recently identified kinetochore protein necessary for chromosome biorientation (Porter et al., 2007 (Porter et al., , 2013 . Depletion of HCF-1, or THAP11 and ZNF143, was sufficient to reduce BUB1B, BOD1, and RANGAP1 expression. ESCO2 expression has been previously shown to involve ZNF143 (Nishihara et al., 2010) . Unlike previous reports Herr, 2003, 2004; Tyagi et al., 2007) , we did not observe an increase in G1 phase HeLa cell population upon HCF-1 knockdown. However, based on numerous published studies and our present observation, we speculate that this discrepancy may manifest as the result of RB1 inactivation by HPV18 E7 oncoprotein expressed in these cells, which results in deregulated E2F-target gene expression and G1 to S phase transition (Moody and Laimins, 2010) . Consistent with this possibility, we find that RB-intact T98G glioblastoma and SW620 colon carcinoma cells do arrest in G1 following HCF-1 knockdown. Furthermore, we have previously shown that THAP11 is a cell proliferation factor in SW620 as well as other colon cancer cells and HCF-1 depletion results in significant proliferation defects in these cells as well (J.B.P., unpublished data).
Another feature of this work is the observation that THAP11, ZNF143, and HCF-1 binding at promoters containing THAP11/ extended ZNF143 binding motifs is mutually dependent on all three factors. The extended ZNF143 binding motif, also referred to as Staf binding sequence 2 (SBS2), differs from the canonical ZNF143 binding motif (SBS1) by the addition of a 5 0 ACTACA submotif adjacent to the core TCCCA ZNF143 recognition sequence (Myslinski et al., 2006) . Although shown to be dispensable for ZNF143 binding in vitro, the ACTACA submotif is nonetheless functional, because mutation of this sequence significantly blunts ESCO2 promoter-driven luciferase activity (Nishihara et al., 2010) . In this context, we speculate that the ACTACA submotif may be a sequence specific binding site for THAP11. Structure-function analyses have revealed that THAP proteins bind specific DNA sequences through bipartite recognition of adjacent DNA major and minor grooves (Campagne et al., 2010; Sabogal et al., 2010) . However, THAP11 has been suggested to be a relatively poor DNA binding protein due to its uniquely shortened DNA minor groove binding loop 4 region (Campagne et al., 2010; Gervais et al., 2013; Sabogal et al., 2010) . Because of this, we hypothesize that HCF-1 may serve as a bridge between THAP11 and chromatin-bound ZNF143, thereby enabling stable association of the THAP11-HCF-1 complex to promoters. Consistent with this hypothesis are our results and the recent observation that HCF-1 physically associates with ZNF143 and occupies extended, rather than canonical, ZNF143 binding sites (Michaud et al., 2013; Ngondo-Mbongo et al., 2013) . This model would explain HCF-1-and ZNF143-dependent THAP11 recruitment and, because HCF-1 does not bind DNA directly, also HCF-1's requirement for THAP11 and ZNF143. Less clear, however, is why ZNF143 binding is sensitive to THAP11 and HCF-1 depletion.
Two recent genome-wide investigations have revealed that THAP11, HCF-1, and ZNF143 have at least partially overlapping cistromes (Michaud et al., 2013; Ngondo-Mbongo et al., 2013) . When interpreted in the context of our findings, we suggest that these reports may be indicative of a more broadly relevant THAP11/ZNF143/HCF-1 transcriptional regulatory complex. We note, however, that this interpretation contrasts with the model reported by Ngondo-Mbongo et al. (2013) who suggested that THAP11 and ZNF143 occupancy is mutually exclusive. Their conclusion is based in large part on the inability of recombinant THAP11 and ZNF143 DNA binding domains to simultaneously occupy an extended ZNF143 oligonucleotide probe in electrophoretic mobility shift assays (EMSAs). Because this assay utilizes truncated proteins and is devoid of HCF-1, we suggest that this result likely reflects a limitation of EMSA rather than a misinterpretation of our sequential ChIP results. Nonetheless, we anticipate that additional experimentation will be required to clarify these conflicting results.
In summary, we have identified transcription factors THAP11 and ZNF143 as key determinants of HCF-1 recruitment to, and regulation of, E2F target genes. These findings significantly change our understanding of the mechanism of HCF-1-mediated gene expression and cell proliferation. Furthermore, these results suggest that the THAP11/ZNF143/HCF-1 complex is an important component of the transcriptional regulatory network controlling cell-cycle progression. Future work will be required to elucidate the mechanism of THAP11/ZNF143/HCF-1 directed gene expression and to determine the interplay between this complex and E2F-associated transcriptional regulatory complexes on cell-cycle control genes.
EXPERIMENTAL PROCEDURES
Cell Culture and Cell Synchronization 293T/17, HeLa, SW620, and T98G cells were purchased from ATCC. 293T/17, HeLa, and SW620 cells were maintained in Dulbecco's modified Eagle medium (high glucose) supplemented with 10% fetal bovine serum. T98G were maintained in minimal essential medium supplemented with 10% fetal bovine serum. All cells were grown at 37 C in a humidified cell culture incubator containing 5% CO 2 . HeLa cells were enriched at prometaphase using thymidine-nocodazole block. Cells ($30% confluence) were cultured in medium containing 2 mM thymidine for 18 hr, after which the thymidine-DMEM medium was removed, and culture dishes were rinsed. Cells were then cultured in DMEM medium containing 100 ng/ml nocodazole (Sigma) for 13 hr. HeLa cells were subsequently harvested for the G2/M population (0 hr) or transferred to normal medium and harvested at indicated time points for flow cytometry, immunoblots, or ChIP assays.
RBL1 Promoter Construct Stable Transfection
T98G cells containing chromosomally integrated wild-type or E2F binding site mutant RBL1 promoter constructs were created using phiC31 integrase as previously described (Hillman and Calos, 2012) . Briefly, the luciferase reporter plasmid pGL4.21 (Promega) was modified to contain an attB phiC31 attachment sequence, creating pGL4.21-attB. An RBL1 promoter fragment (À287 to +42) or its tandem E2F binding site mutant (Burkhart et al., 2010) were cloned into pGL4.21-attB. T98G cells were cotransfected with a codonoptimized phiC31 expression vector (Raymond and Soriano, 2007 ) (Addgene plasmid #13795) and either pGL4.21-attB RBL1-WT or pGL4.21-attB RBL1-E2F mutant plasmids using FugeneHD (Promega) transfection reagent. Pools of stably transfected cells were selected with 1 mg/ml puromycin. Full details are available in Supplemental Experimental Procedures.
Retroviral shRNA Transduction and siRNA Transfection Nonsilencing control, THAP11, and HCF-1 pSuper.Retro.Puro retroviral shRNA expression vectors have been described previously . ZNF143, E2F1, E2F4, DP1, and human papillomavirus type 18 (HPV18) E7 shRNAs were cloned into pSuper.Retro.Puro using the sequences listed in Supplemental Experimental Procedures. VSV-G pseudotyped retrovirus was produced and used to spin-infect cells as previously described . Two days posttransduction, cells were split into media containing 2 mg/ml puromycin and selected for at least 2 days or as indicated.
For knockdown using siRNA, HeLa cells were transfected with 30 nM nonsilencing control siRNA (Thermo Scientific) or 15 nM each of THAP11 and ZNF143 siRNA using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. Transfected HeLa cells were harvested for RNA and protein isolation after 72 hr incubation. THAP11 and ZNF143 siRNA oligonucleotides corresponding to the shRNA targeting sequences were synthesized by Thermo Scientific.
Immunoblots and Quantitative RT-PCR Whole-cell extracts were prepared from cells expressing shRNA 4 days posttransduction and immunoblotted as previously described . Antibodies and working dilutions used for immunoblotting are provided in Supplemental Experimental Procedures.
Total RNA was prepared from shRNA-expressing cells 4 days posttransduction or from siRNA-transfected cells 3 days posttransfection and analyzed by quantitative RT-PCR as previously described .
Immunoprecipitation, ChIP, Sequential ChIP, and ChIP-Western Nuclear extract preparation and coimmunoprecipitation were performed as described previously with minor modifications. Full details are provided in Supplemental Experimental Procedures. Immunoprecipitation was performed using the following antibodies: THAP11 (R&D Systems #MAB5727, 2 mg) and HCF-1 (Bethyl Laboratories #A301-399A, 1 mg).
ChIP and sequential ChIP (ChIP-reChIP) assays were performed as described . Antibodies used for ChIP are as follows: THAP11 (R&D Systems #MAB5727, 2 mg), HCF-1 (Bethyl Laboratories #A301-399A, 1 mg), ZNF143 (Proteintech Group #16618-1-AP, 2 mg), E2F1 (Millipore #05-379, 2 mg), E2F3 (Millipore #05-551, 2 mg), E2F4 (Santa Cruz Biotechnology #A-20x, 2 mg), DP1 (Santa Cruz Biotechnology #sc-610x, 2 mg).
ChIP-Western assays were performed identically as conventional ChIP except that following the final RIPA wash (50 mM HEPES-KOH [pH 7.6], 500 mM LiCl, 1 mM EDTA, 0.7% Na-Deoxycholate, 1% IGEPAL CA-630) beads were washed twice with 10 mM Tris-HCl (pH 7.6), 50 mM NaCl, 2 mM MgCl2, 0.1% Triton X-100 and resuspended in 100 ml of the same buffer. Where indicated, 1 ml (250 U) of Benzonase nuclease (Sigma) was added and samples were incubated for 1 hr at 25 C in a Thermomixer (Eppendorf) at 900 rpm. The beads then washed three times with ice-cold RIPA and once with 10 mM Tris (pH 7.6), 1 mM EDTA, and 50 mM NaCl. Twenty percent of the bead-bound immunoprecipitated material was reserved for qPCR, and the remaining 80% was eluted in 2 3 Laemelli sample buffer containing 5% b-mercaptoethanol at 100 C for 5 min. Eluted protein was separated by SDS-PAGE, transferred to nitrocellulose, and immunoblotted as described above.
Flow Cytometry
Cell-cycle analysis was determined by flow cytometry using propidium iodide (PI)-stained cells as described previously (Loomis et al., 2009) , with minor modifications. Apoptosis was determined by flow cytometry using Annexin V/PI staining reagents (Invitrogen) according to manufacturer's instructions. Full details of flow cytometry procedures are provided in Supplemental Experimental Procedures.
In Silico Analyses
To determine potential THAP11/HCF-1 binding sites colocalized with E2F1, E2F1-bound loci determined by ENCODE consortium (Consortium, 2011) were scanned using MAST software v4.8.1 ) and a previously determined THAP11 DNA motif (Dejosez et al., 2010) .
ChIP-seq data were retrieved from the NCBI Sequence Read Archive and mapped to the human hg19 genome using bowtie (v1.0.0, http://bowtie-bio. sourceforge.net). Peaks were called using HOMER (v4.3, http://homer.salk. edu). Colocalized peaks were defined as those with centers no more than 500 bp apart. To determine chromatin occupancy correlation, tag densities surrounding colocalized peaks were compared. E2F1-HCF-1 peaks devoid of THAP11/ZNF143 were defined as E2F1 peaks directly overlapping HCF-1 with no THAP11 or ZNF143 peaks called within 500 bp. Full details are available in Supplemental Experimental Procedures.
Statistics
Student's t test and Pearson product-moment correlation coefficients were calculated using GraphPad Prism version 5. 
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
